SCHEMBL25910642

SCHEMBL25910642

C=C(C)c1cc(OC[C@H](C)N2CCC3(CC2)C(=O)Nc2ccc(C)cc23)cc(F)c1S(C)(=O)=O

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.32
ADRA2B P18089 1/20 0.30
PIK3CD O00329 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25318629 0.80 PGR (0.38) METADRA2BMEN1KMT2A
SCHEMBL25315809 0.80 PGR (0.38) METADRA2BMEN1KMT2A
SCHEMBL25908381 0.77 HTR1A (0.41)
SCHEMBL25908768 0.76 ALK (0.38)
SCHEMBL25933820 0.71 TRIM24 (0.42) MET
SCHEMBL25316061 0.71 SIGMAR1 (0.41) MET
SCHEMBL25316319 0.71 SIGMAR1 (0.41) MET
SCHEMBL30507166 0.71 SIGMAR1 (0.41) MET
SCHEMBL30506786 0.71 SIGMAR1 (0.41) MET
SCHEMBL25909333 0.71 IP6K1 (0.38) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed